reason report
decent quarter dental rebound pt
bottom line updat estim follow
result rais adj ep estim updat guidanc
effect recent tax reform legisl adj ep guidanc
rais mid-point reflect tax reform rais
outlook dental anim health segment given stronger-than-
expect sale quarter na dental consum grew y/i
despit headwind na equip sale post growth
y/i anim health post sequenti deceler growth
continu deliv steadi return remain mp stock
price target declin increas adj ep
estim off-set lower multipl assumpt due pend ftc
complaint continu worri entranc
guidanc rais tax reform adj ep guidanc
rais prior rang
compar leerink/consensu
cfo steve paladino explain guidanc reflect two
chang effect tax reform one-tim bonu grant
employe later mr paladino also describ
compani factor litig expens guidanc due
recent ftc complaint compani guid expect
effect tax rate estim lower tax rate
add account increas guidanc
ftc complaint dismiss meritless ceo stanley
bergman sound upset comment recent ftc complaint
link complaint link note mr bergman character
alleg merit-less outrag manag explain
sever time ftc lawsuit seek injunct relief rather
monetari damag provid mani illumin comment
vehement dismiss complaint ftc alleg
manag describ guidanc legal cost
factor trial expect begin octob
net debt total capit
compani inform leerink partner llc research
revenu billion dollar
ep adjust non-recur item includ extra week
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
strong growth quarter surpris rebound
intern sale growth y/i quarter na
consum pose growth neg impact
previous disclos dso contract loss januari
na dental equip sale grew y/i equip expect
remain strong manag describ dentist invest
practic
consum weak like persist near-
term market remain good medium-term show
improv intern dental consum merchandis sale
quarter first decreas sinc manag
describ expect remain weak near-term
medium-term expect report improv
intern segment germani franc itali call
market contribut consum weak
dental equip sale growth help off-set consum
weak overal segment post intern growth
total growth
medic segment continu driven larg exist
custom medic segment continu benefit focu
larg group practic space manag cite organ growth
exist larg custom driver medic sale growth
surpris medic revenu trail leerink/consensu
quarter given strong flu season na local intern growth
y/i head estim manag highlight
believ medic divis continu exceed growth
rate broader office-bas practition market reflect firm
abil penetr grow larg practic
anim sale solid growth slow sequenti
continu branch-out anim health market manag
detail recent purchas anim health space brazil
purchas abas sao paulo-bas veterinari product
bolster acquisit growth
na anim health intern sale growth decent show
deceler local intern intern anim
growth show slight down-tick manag
describ anim end market healthi benefit
consist deliveri innov product well strong custom
model updat increas adj ep
guidanc effect tax reform continu work around
impact amazon though appear success
continu gain share mani end market compani
remain share repurchas maintain market
perform rate pt declin higher
ep off-set lower multipl given risk tie ftc
complaint on-going amazon concern
inc one largest distributor medic dental veterinari suppli
office-bas practic throughout world major compani busi base
dental suppli anim health physician offic practic believ henri
schein well-run busi organ growth rate sever compani major divis
modest though recent re-acceler make us posit sever recent
acquisit drive accret off-set global util headwind
overal believ compani sector present attract invest opportun
higher rate revenu earn growth rel result rate
share market perform
stock current trade ep premium
drug distribut pbm group esrx
trade ahead competitor pbm sub-sector trade averag
ep estim next month expect share
trade ep would put stock price target
slightli behind histor averag ntm ep believ
price target reason given hsic consist abil grow market share deliv
upsid expect acquisit believ current multipl alreadi reflect
cool sentiment believ share repres best risk/reward profil
time believ grow market rate manag take
step expand margin believ current premium alreadi reflect growth profil
believ compani within hcit pharma distribut sector repres better
invest time price target review pend complet analysi
earn result
competit relianc manufactur healthcar distribut industri north
america intern highli competit distributor compet basi price
product offer custom servic valu ad product servic competitor obtain
exclus right manufactur distribut certain product manufactur bypass
distributor altogeth could advers impact earn larg competitor
especi abroad use size increas price pressur group purchas
organ gpo larg provid may also demand lower price addit
manufactur disrupt shortag result unabl meet custom
demand certain product seen flu vaccin shortag issu
supplier relationship advers impact firm earn
acquisit restructur one largest player alternate-car market
made numer acquisit domest intern market
acquisit joint ventur involv numer risk may integr well
manag intend success integr acquisit past
immedi short-term impact bottom line drag earn year
come acquisit may result loss custom product line acquir busi
may unintend effect area oper cost increas relat
restructur integr new busi advers impact firm
earn margin
season quarterli fluctuat tradit sale higher third
fourth quarter result end year custom purchas pattern well flu
season ill quarterli earn impact number factor includ
sever flu season product avail time price chang product releas
vendor advers impact revenu firm
govern regul healthcar reform custom
healthcar industri highli regul local state feder law firm may need
adapt procedur price result polici chang govern agenc
pressur reduc budget deficit balloon healthcar cost frequent target
enact healthcar reform reduct reimburs rate public and/or
privat insur program could advers impact revenu profit margin foreign
domest tax law also subject chang current interpret subject
scrutini challeng could advers impact firm earn
revenu
revenu
revenu
net sale
adjust incom tax
incom tax
equiti incom affili
adjust incom cont op
net incom cont op
ep continu oper
adjust ep continu oper
